Hepatitis E virus infects neurons and brains

Journal of Infectious Diseases

Volumn 215, Issue 8, 2017, Pages 1197-1206

  Zhou, Xinying ^a   Huang, Fen ^b   Xu, Lei ^a   Lin, Zhanmin ^a   De Vrij, Femke M S ^a   Ayo Martin, Ane C ^a   Van Der Kroeg, Mark ^a   Zhao, Manzhi ^a   Yin, Yuebang ^a   Wang, Wenshi ^a   Cao, Wanlu ^a   Wang, Yijin ^a   Kushner, Steven A ^a   Peron, Jean Marie ^c,d   Alric, Laurent ^d,e   De Man, Robert A ^a   Jacobs, Bart C ^a   Van Eijk, Jeroen J ^f   Aronica, Eleonora M A ^g   Sprengers, Dave ^a   Metselaar, Herold J ^a   De Zeeuw, Chris I ^a,h   Dalton, Harry R ^i,j   Kamar, Nassim ^c,e,k   Peppelenbosch, Maikel P ^a   Pan, Qiuwei ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CHU PURPAN   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f JEROEN BOSCH HOSPITAL   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

ⁱ UNIVERSITY OF EXETER   (United Kingdom)

^j UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^k CHU RANGUEIL   (France)

more..

Author keywords

Central nervous system; Cerebrospinal fluid; Hepatitis E virus; Peripheral nervous system

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN; VIRAL PROTEIN; VIRUS RNA; ANTIVIRUS AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN INFECTION; BRAIN TISSUE; CELL LINEAGE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HAPLORHINI; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; IN VITRO STUDY; INFECTION RISK; INFECTION SENSITIVITY; MALE; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; OFF LABEL DRUG USE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; VIRUS PARTICLE; VIRUS SHEDDING; ADULT; AGED; ANIMAL; BAGG ALBINO MOUSE; BRAIN; C57BL MOUSE; DRUG EFFECTS; GUILLAIN BARRE SYNDROME; LIVER; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; RHESUS MONKEY; TUMOR CELL LINE; VIROLOGY; VIRUS REPLICATION;

ADULT; AGED; ANIMALS; ANTIVIRAL AGENTS; BRAIN; CELL LINE, TUMOR; CEREBROSPINAL FLUID; FEMALE; GUILLAIN-BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INTERFERON-ALPHA; LIVER; MACACA MULATTA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; NEURONS; RIBAVIRIN; RNA, VIRAL; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 85028490570     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix079     Document Type: Article

References (39)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379:2477–88.
2. Zhou X, de Man RA, de Knegt RJ, Metselaar HJ, Peppelenbosch MP, Pan Q. Epidemiology and management of chronic hepatitis E infection in solid organ transplantation: a comprehensive literature review. Rev Med Virol 2013; 23:295–304.
3. Debing Y, Moradpour D, Neyts J, Gouttenoire J. Update on hepatitis E virology: implications for clinical practice. J Hepatol 2016.
4. Dalton HR, Kamar N, van Eijk JJ, et al. Hepatitis E virus and neurological injury. Nat Rev Neurol 2016; 12:77–85.
5. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384:1766–73.
6. Kamar N, Marion O, Abravanel F, Izopet J, Dalton HR. Extrahepatic manifestations of hepatitis E virus. Liver Int 2016; 36:467–72.
7. Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep (Oxf) 2016; 4:1–15.
8. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014; 27:116–38.
9. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17:173–9.
10. Bandyopadhyay D, Ganesan V, Choudhury C, et al. Two uncommon causes of Guillain-Barré syndrome: Hepatitis E and Japanese Encephalitis. Case Rep Neurol Med 2015; 2015:759495.
11. Silva M, Wicki B, Tsouni P, et al. Hepatitis E virus infection as a direct cause of neuralgic amyotrophy. Muscle Nerve 2016; 54:325–7.
12. van Eijk JJ, Madden RG, van der Eijk AA, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology 2014; 82:498–503.
13. Pischke S, Hartl J, Pas SD, et al. Hepatitis E virus infection beyond the liver? J Hepatol 2016. doi: 10.1016/j.jhep.2016.11.016. [Epub ahead of print]
14. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet 2016; 388:717–27.
15. Shukla P, Nguyen HT, Faulk K, et al. Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination. J Virol 2012; 86:5697–707.
16. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci USA 2011; 108:2438–43.
17. de Esch CE, Ghazvini M, Loos F, et al. Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation. Stem Cell Reports 2014; 3:548–55.
18. Huang F, Yang C, Zhou X, Yu W, Pan Q. Rhesus macaques persistently infected with hepatitis E shed virus into urine. J Hepatol 2016.
19. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991; 252:854–6.
20. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol 2015; 39:20–7.
21. Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q. Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants. Curr Opin Infect Dis 2014; 27:303–8.
22. Wang Y, Zhou X, Debing Y, et al. Calcineurin inhibitors stimulate and myco-phenolic acid inhibits replication of hepatitis E virus. Gastroenterology 2014; 146:1775–83.
23. Zhou X, Xu L, Wang W, et al. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection. J Viral Hepat 2016; 23:294–304.
24. Zhou X, Wang Y, Metselaar HJ, Janssen HL, Peppelenbosch MP, Pan Q. Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway. J Hepatol 2014; 61:746–54.
25. Woolson KL, Forbes A, Vine L, et al. Extra-hepatic manifestations of autochtho-nous hepatitis E infection. Aliment Pharmacol Ther 2014; 40(11-12):1282–91.
26. Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010; 10:1321–4.
27. van den Berg B, van der Eijk AA, Pas SD, et al. Guillain-Barré syndrome associated with preceding hepatitis E virus infection. Neurology 2014; 82:491–7.
28. Takahashi H, Tanaka T, Jirintai S, et al. A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch Virol 2012; 157:235–46.
29. Drave SA, Debing Y, Walter S, et al. Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J Viral Hepat 2016; 23:512–21.
30. Helsen N, Debing Y, Paeshuyse J, et al. Stem cell-derived hepatocytes: A novel model for hepatitis E virus replication. J Hepatol 2016; 64:565–73.
31. Zhou X, Xu L, Wang Y, et al. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication. Antiviral Res 2015; 124:11–9.
32. Huang F, Zhang W, Gong G, et al. Experimental infection of Balb/c nude mice with Hepatitis E virus. BMC Infect Dis 2009; 9:93.
33. Yu W, Yang C, Bi Y, et al. Characterization of hepatitis E virus infection in tree shrew (Tupaia belangeri chinensis). BMC Infect Dis 2016; 16:80.
34. Han J, Lei Y, Liu L, et al. SPF rabbits infected with rabbit hepatitis E virus isolate experimentally showing the chronicity of hepatitis. PLOS One 2014; 9:e99861.
35. Li W, Sun Q, She R, et al. Experimental infection of Mongolian gerbils by a genotype 4 strain of swine hepatitis E virus. J Med Virol 2009; 81:1591–6.
36. Shi R, Soomro MH, She R, et al. Evidence of hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system. J Viral Hepat 2016; 23:930–9.
37. Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 2016; 64:37–43.
38. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025–7.
39. Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011; 155:479–80.